Skip to main content
See every side of every news story
Published loading...Updated

First Measurable Molecular Difference Found in Autistic Brains

Autistic adults show about 15% lower mGlu5 receptor availability linked to altered excitatory brain activity measured by EEG, suggesting a molecular basis for autism traits.

  • In adult participants, the team reported 15% lower metabotropic glutamate receptor 5 availability across brain regions in autistic adults, largest in the cerebral cortex compared with neurotypical control participants.
  • Motivated by long‑standing hypotheses, the Yale School of Medicine research team assessed glutamatergic receptor density and related it to electroencephalogram measures to address unclear molecular mechanisms in autism.
  • Fifteen autistic participants had EEG testing, and Spearman's rho correlation method showed mGlu5 availability correlated with EEG power‑spectrum slope, including cerebral cortex r=0.67, with multimethod analyses revealing associations.
  • The study suggests lower brain‑wide mGlu5 availability may help stratify autism and inform mGlu5‑targeted therapeutics, while electroencephalography offers clinicians and researchers a cheaper, accessible tool.
  • This finding positions mGlu5 as a measurable signature, with the Yale research team planning studies in children and adolescents using newer lower-radiation PET techniques to explore developmental timing of mGlu5 differences.
Insights by Ground AI

8 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

thetransmitter.org broke the news in on Tuesday, December 16, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal